Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Korzinov

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Physical Review. A, Atomic, Molecular, and Optical Physics|December 15, 1992
Symmetry breaking in nonequilibrium systems: Interaction of defectsKorzinov, Rabinovich, Tsimring
Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics|November 1, 1996
Rotating spirals in a Faraday experimentKiyashko, Korzinov, Rabinovich, et al.
Molekuliarnaia Biologiia|April 9, 2008
[Statistical analysis of DNA sequences nearby splicing sites]O M Korzinov, T V Astakhova, P K Vlasov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 27, 2022
[New opportunities for non-drug treatment of insomnia using sleep normalization medical device SONYA]D A Degterev, E A Korabelnikova, O M Korzinov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|July 19, 2014
[Preclinical study of the new anti-influenza drug candidate AV0038 (ethyl 2-(dimethylaminomethyl)-5-hydroxy-1-methyl-6-(pyridin-3-yl)-1H-indole-3-carboxylate)]A V Ivashchenko, P M Iamanushkin, O D Mit'kin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|December 19, 2014
[Antiviral activity in vitro and pharmacokinetics of HCV entry inhibitor AVR560]A V Ivashchenko, P M Iamanushkin, O D Mit'kin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 6, 2015
[Preclinical study of safety of the new pharmacological substance AV0012 to treat hepatitis C]A V Ivashchenko, P M Iamanushkin, O D Mit'kin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|August 1, 2014
[Preclinical study of AV0012 early stage inhibitor of hepatitis C virus infection: I. In vitro ADME and pharmacokinetics]A V Ivashchenko, P M Iamanushkin, O D Mit'kin, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitorsAngela G Koryakova, Yan A Ivanenkov, Elena A Ryzhova, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Physical Review. A, Atomic, Molecular, and Optical Physics|December 15, 1992
Symmetry breaking in nonequilibrium systems: Interaction of defectsKorzinov, Rabinovich, Tsimring
Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics|November 1, 1996
Rotating spirals in a Faraday experimentKiyashko, Korzinov, Rabinovich, et al.
Molekuliarnaia Biologiia|April 9, 2008
[Statistical analysis of DNA sequences nearby splicing sites]O M Korzinov, T V Astakhova, P K Vlasov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 27, 2022
[New opportunities for non-drug treatment of insomnia using sleep normalization medical device SONYA]D A Degterev, E A Korabelnikova, O M Korzinov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|July 19, 2014
[Preclinical study of the new anti-influenza drug candidate AV0038 (ethyl 2-(dimethylaminomethyl)-5-hydroxy-1-methyl-6-(pyridin-3-yl)-1H-indole-3-carboxylate)]A V Ivashchenko, P M Iamanushkin, O D Mit'kin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|December 19, 2014
[Antiviral activity in vitro and pharmacokinetics of HCV entry inhibitor AVR560]A V Ivashchenko, P M Iamanushkin, O D Mit'kin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 6, 2015
[Preclinical study of safety of the new pharmacological substance AV0012 to treat hepatitis C]A V Ivashchenko, P M Iamanushkin, O D Mit'kin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|August 1, 2014
[Preclinical study of AV0012 early stage inhibitor of hepatitis C virus infection: I. In vitro ADME and pharmacokinetics]A V Ivashchenko, P M Iamanushkin, O D Mit'kin, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitorsAngela G Koryakova, Yan A Ivanenkov, Elena A Ryzhova, et al.
Pageof 1